Asepha Secures $4M Seed Funding to Revolutionize Pharmacy Operations with AI

Asepha, a startup specializing in AI-driven pharmacy automation, has successfully closed a $4 million Seed funding round. The investment was led by Glasswing Ventures and Core Innovation Capital, with participation from Panache, RedBud, MGV, Ripple Ventures, and Front Row Ventures. This funding underscores the growing recognition of AI's potential to transform pharmacy operations by alleviating staffing shortages and reducing the time pharmacists spend on administrative tasks.

Founded in 2023 by Eunice Wu and Can Uncu, Asepha addresses critical bottlenecks in pharmacy care through its suite of AI agents. These include an OCR prescription entry agent with 96% accuracy in processing handwritten prescriptions, a call agent automating 70% of inbound calls, and a browser navigation agent for administrative tasks. These tools not only streamline operations but also improve accuracy and efficiency, as evidenced by pharmacists preferring Asepha's AI responses over human responses 71% of the time in trials.

The funding will enable Asepha to expand its engineering and go-to-market teams, grow its U.S. presence with a new New York City office, and strengthen partnerships. The company has already attracted Fortune 50 enterprise customers, highlighting its early impact in the pharmacy sector. Eunice Wu, CEO and Co-Founder, emphasized the importance of focusing on patient care by reducing administrative burdens, while CTO Can Uncu highlighted the role of AI in restructuring industry workflows responsibly.

Investors Rudina Seseri of Glasswing Ventures and Edwin Loredo of Core Innovation Capital praised Asepha's focused approach and alignment with demographic trends, noting the urgent need for solutions to the pharmacy labor gap. Asepha's innovative use of AI agents presents a promising avenue for enhancing pharmacy operations and patient access to care.